San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo Advisors:
Die Analysten von Wells Fargo haben das Rating "equal-weight" und…
…
Bad Marienberg (www.aktiencheck.de) - Johnson & Johnson: Kursziel steigt auf 176 USD – Analyst bleibt dennoch zurückhaltend
Die Investmentbank Morgan Stanley…
Key PointsJohnson & Johnson continues to generate plenty of free cash flow to cover its dividend. The healthcare giant also…
…
Key PointsExxonMobil has the best dividend growth track record in the oil industry. Johnson & Johnson has increased its dividend…
…
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025.…
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025.…
Key PointsJohnson & Johnson delivered a "beat and raise" quarter. Results were bolstered by the new acquisition of Intra-Cellular, marking…
The Dow Jones Industrial Average is up Wednesday afternoon with shares of Johnson & Johnson and Amgen seeing positive momentum…
These are the stocks posting the largest moves in midday trading.…
Image source: The Motley Fool.
DATEWednesday, July 16, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Joaquin DuatoChief…
Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…
Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…
…
The headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the quarter ended June…
Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…
NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) blickt nach einem überraschend guten zweiten Quartal zuversichtlicher auf das…
These are the stocks posting the largest moves in premarket trading.…
Johnson & Johnson reported second-quarter profit and raised its full-year sales forecast by around $2 billion on Wednesday as strong…
Johnson & Johnson (NYSE:JNJ) shares edged higher premarket as the healthcare firm reported an earnings beat for the second quarter…
Key PointsKenvue is spending big to drum up demand for its diversified product portfolio.The companys weak results reflect pressure on…
Key PointsJohnson & Johnson reports earnings on Wednesday.Investors may be paying attention to tariff-related developments more so than the companys…
Key PointsThe investment advisor sold 38,037 shares for a total of $6.31 million in Q2 2025.Move removes JNJ from portfolio,…
Key PointsJohnson & Johnson has delivered excellent returns to its long-term shareholders. One key factor behind the companys success is…
Johnson & Johnson (JNJ) possesses the right combination of the two key ingredients for a likely earnings beat in its…
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…
Key PointsJohnson & Johnson is a Dividend King.The stock offers an attractive 3.4% dividend yield.Another healthcare stock has a 7.4%…
Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…
MU gains 42.5% YTD as AI demand fuels DRAM growth, while JNJ and HD navigate pricing, pipeline, and macro headwinds.…
Johnson & Johnson (JNJ) concluded the recent trading session at $155.92, signifying a +2.08% move from its prior days close.…
…
Detailed price information for Jabil Circuit (JBL-N) from The Globe and Mail including charting and trades.…